Rosen, a leading investor firm, continues to investigate securities claims against sonoma pharmaceuticals, inc. – snoa

New york--(business wire)--rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of sonoma pharmaceuticals, inc. (nasdaq: snoa) resulting from allegations that sonoma may have issued materially misleading business information to the investing public. on november 17, 2020, after market hours, sonoma filed a form 8-k with the u.s. securities and exchange commission announcing that sonoma's “unaudited condensed consolidate
SNOA Ratings Summary
SNOA Quant Ranking